Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - olsalazine sodium - oral solution - 50mg/1ml

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - olsalazine sodium - oral capsule - 250mg

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - olsalazine sodium - oral tablet - 500mg

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - olsalazine sodium - oral capsule - 250mg

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - olsalazine sodium - oral tablet - 500mg

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - olsalazine sodium - oral capsule - 250mg

Canadá - inglés - Health Canada

atnahs pharma uk limited - olsalazine sodium - capsule - 250mg - olsalazine sodium 250mg - anti-inflammatory agents

Australia - inglés - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - olsalazine sodium, quantity: 250 mg - capsule - excipient ingredients: titanium dioxide; gelatin; magnesium stearate; caramel; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid; purified water; industrial methylated spirit; ammonia - indications as at 19 december 2000: treatment of ulcerative colitis in patients intolerant of sulphasalazine.

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

atnahs pharma uk limited - olsalazine sodium - capsule - 250 milligram(s) - aminosalicylic acid and similar agents; olsalazine

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

atnahs pharma uk limited - olsalazine sodium - tablet - 500 milligram(s) - aminosalicylic acid and similar agents; olsalazine